Katherine Beebe - Jul 26, 2023 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Signature
/s/ Katherine Beebe DeVarney
Stock symbol
TTNP
Transactions as of
Jul 26, 2023
Transactions value $
$0
Form type
4
Date filed
7/28/2023, 05:45 PM
Previous filing
Jan 5, 2022
Next filing
Oct 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock Award $0 +50K $0.00 50K Jul 26, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTNP Option to Purchase Common Stock Award $0 +100K $0.00 100K Jun 29, 2023 Common Stock 100K $1.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant.
F2 The options were approved by the Issuer's Board of Directors on August 15, 2022. The options were conditioned on the approval by the Issuer's stockholders of an increase in the number of shares available for issuance under the 2015 Omnibus Equity Incentive Plan, which approval occurred on June 29, 2023. The exercise price of the options is equal to the closing price of the Issuer's common stock on August 15, 2022.